Calamos Advisors LLC Abb Vie Inc. Transaction History

Calamos Advisors LLC

$16.1 Billion
Q3 2024

A detailed history of Calamos Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Calamos Advisors LLC holds 442,774 shares of ABBV stock, worth $74.3 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

442,774

Previous 449,504 1.5%

Holding current value

$74.3 Million

Previous $77.1 Million 13.41%

% of portfolio

0.54%

Previous 0.49%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$163.84 - $199.33 $1.1 Million - $1.34 Million	-6,730 Reduced 1.5%	442,774 $87.4 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $1.72 Million - $2.01 Million	-11,105 Reduced 2.41%	449,504 $77.1 Million
Q1 2024 May 08, 2024	SELL	$159.82 - $182.1 $1.26 Million - $1.43 Million	-7,859 Reduced 1.68%	460,609 $83.9 Million
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $539,116 - $607,172	-3,918 Reduced 0.83%	468,468 $72.6 Million
Q3 2023 Oct 25, 2023	BUY	$133.59 - $154.65 $77,215 - $89,387	578 Added 0.12%	472,386 $70.4 Million
Q2 2023 Jul 28, 2023	SELL	$132.51 - $164.9 $25,706 - $31,990	-194 Reduced 0.04%	471,808 $63.6 Million
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $6.31 Million - $7.27 Million	-43,633 Reduced 8.46%	472,002 $75.2 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $9.6 Million - $11.5 Million	-69,387 Reduced 11.86%	515,635 $0
Q3 2022 Oct 24, 2022	SELL	$134.21 - $153.93 $8.18 Million - $9.38 Million	-60,958 Reduced 9.44%	585,022 $78.5 Million
Q2 2022 Aug 01, 2022	BUY	$137.62 - $174.96 $1.75 Million - $2.22 Million	12,694 Added 2.0%	645,980 $98.9 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $11.4 Million - $14.2 Million	86,633 Added 15.85%	633,286 $103 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $1.63 Million - $2.07 Million	15,202 Added 2.86%	546,653 $74 Million
Q3 2021 Oct 26, 2021	BUY	$106.4 - $120.78 $6.6 Million - $7.49 Million	62,014 Added 13.21%	531,451 $57.3 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $21.4 Million - $23.9 Million	203,536 Added 76.55%	469,437 $52.9 Million
Q1 2021 Apr 12, 2021	BUY	$102.3 - $112.62 $829,346 - $913,010	8,107 Added 3.14%	265,901 $28.8 Million
Q4 2020 Jan 27, 2021	SELL	$80.49 - $108.67 $919,195 - $1.24 Million	-11,420 Reduced 4.24%	257,794 $27.6 Million
Q3 2020 Oct 26, 2020	SELL	$85.91 - $100.83 $2.03 Million - $2.38 Million	-23,594 Reduced 8.06%	269,214 $23.6 Million
Q2 2020 Jul 27, 2020	BUY	$73.37 - $98.18 $2.55 Million - $3.41 Million	34,714 Added 13.45%	292,808 $28.7 Million
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $1.62 Million - $2.46 Million	-25,124 Reduced 8.87%	258,094 $19.7 Million
Q4 2019 Jan 15, 2020	SELL	$72.13 - $90.25 $226,920 - $283,926	-3,146 Reduced 1.1%	283,218 $25.1 Million
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $1.68 Million - $2.01 Million	26,601 Added 10.24%	286,364 $21.7 Million
Q2 2019 Aug 07, 2019	SELL	$65.7 - $83.98 $574,743 - $734,657	-8,748 Reduced 3.26%	259,763 $18.9 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $29.2 Million - $34.3 Million	-378,020 Reduced 58.47%	268,511 $21.6 Million
Q4 2018 Jan 24, 2019	SELL	$77.85 - $96.01 $2.81 Million - $3.46 Million	-36,057 Reduced 5.28%	646,531 $59.6 Million
Q3 2018 Oct 22, 2018	SELL	$88.91 - $98.84 $7.36 Million - $8.18 Million	-82,726 Reduced 10.81%	682,588 $64.6 Million
Q2 2018 Jul 17, 2018	SELL	$89.78 - $106.23 $32.5 Million - $38.4 Million	-361,697 Reduced 32.09%	765,314 $70.9 Million
Q1 2018 Apr 13, 2018	BUY	$92.01 - $123.21 $24.5 Million - $32.8 Million	266,165 Added 30.92%	1,127,011 $107 Million
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $58.9 Million - $64.6 Million	657,967 Added 324.31%	860,846 $83.3 Million
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $475,189 - $606,963	6,803 Added 3.47%	202,879 $18 Million
Q2 2017 Aug 09, 2017	BUY	N/A	196,076	196,076 $14.2 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Abb Vie Inc. Transaction History